ReviewJournal of thoracic disease2013
Intensive care unit and lung cancer: when should we intubate?
Review in Journal of thoracic disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 33 citations in OpenAlex.
- Combining computational and experimental approaches: a novel pH-responsive PVA-stabilized MXene nanocarriers/doxorubicin delivery system with enhanced efficacy for targeted lung cancer therapeutics.Naunyn-Schmiedeberg's archives of pharmacology · 2025Article
- Observational
- Prognostic factors for advanced lung cancer patients with do-not-intubate order in intensive care unit: a retrospective study.BMC pulmonary medicine · 2022Article
- Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs).Annals of intensive care · 2018Article
- The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer.Cancer research and treatment · 2018Article
- Target delivery of doxorubicin tethered with PVP stabilized gold nanoparticles for effective treatment of lung cancer.Scientific reports · 2018Article
- Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity.International journal of nanomedicine · 2018Article
- What is the role of empirical treatment for suspected invasive candidiasis in non-neutropenic non transplanted patients in the intensive care unit?-Empiricus strikes back!Journal of thoracic disease · 2016Article
- Minimally invasive procedures.Annals of translational medicine · 2015Review
- Pneumothorax: an up to date "introduction".Annals of translational medicine · 2015Review
- Chest drainage systems in use.Annals of translational medicine · 2015Article
- Pneumothorax as a complication of central venous catheter insertion.Annals of translational medicine · 2015Article
- Heimlich valve and pneumothorax.Annals of translational medicine · 2015Review
- Pneumothorax from diagnosis to treatment, hands on course: Part II.Annals of translational medicine · 2015Article
- Pacemaker insertion.Annals of translational medicine · 2015Article
- Postoperative pain management.Journal of thoracic disease · 2015Review
- Physiology of the pleural space.Journal of thoracic disease · 2015Review
- Pleura space anatomy.Journal of thoracic disease · 2015Review
- Barotrauma and pneumothorax.Journal of thoracic disease · 2015Review
- Semi-Fowler vs. lateral decubitus position for thoracoscopic sympathectomy in treatment of primary focal hyperhidrosis.Journal of thoracic disease · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer still remains the leading cause of cancer death among males. Several new methodologies are being used in the everyday practise for diagnosis and staging. Novel targeted therapies are being used and others are being investigated. However; early diagnosis still remains the cornerstone for efficient treatment and disease management. Lung cancer patients requires in many situations intensive care unit (ICU) admission, either due to the necessity for supportive care until efficient disease symptom control (respiratory distress due to malignant pleural effusion) or disease adverse effect management (massive pulmonary embolism). In any case guidelines indicating the patient that has to be intubated have not yet been issued. In the current review we will present current data and finally present an algorithm based on the current published information for lung cancer patients that will probably benefit from admission to the ICU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.